Hemophilia B Leyden and once mysterious cis-regulatory mutations

Trends in Genetics

Volumn 30, Issue 1, 2014, Pages 18-23

  Funnell, Alister P W ^a   Crossley, Merlin ^a  

^a UNIVERSITY OF NEW SOUTH WALES   (Australia)

Author keywords

Gene regulation; Hemophilia; Promoter mutations; Regulatory mutations; SNPs

Indexed keywords

BLOOD CLOTTING FACTOR 9; TRANSCRIPTION FACTOR;

BINDING SITE; CHILDHOOD DISEASE; GENE CONTROL; GENE EXPRESSION; GENE MAPPING; GENE MUTATION; GENETIC ASSOCIATION; GENETIC DISORDER; HEMOPHILIA B; HEMOPHILIA B LEYDEN; HUMAN; HUMAN GENOME; IN VIVO STUDY; PRIORITY JOURNAL; PROMOTER REGION; PUBERTY; REVIEW; SINGLE NUCLEOTIDE POLYMORPHISM;

GENE REGULATION; HEMOPHILIA; PROMOTER MUTATIONS; REGULATORY MUTATIONS; SNPS;

AMINO ACID SEQUENCE; DNA-BINDING PROTEINS; FACTOR IX; GENE EXPRESSION REGULATION; HEMOPHILIA B; HUMANS; MOLECULAR SEQUENCE DATA; MUTATION; POLYMORPHISM, SINGLE NUCLEOTIDE; PROMOTER REGIONS, GENETIC; TRANSCRIPTION FACTORS;

EID: 84891161676     PISSN: 01689525     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tig.2013.09.007     Document Type: Review

References (69)

1. Lander E.S., et al. Initial sequencing and analysis of the human genome. Nature 2001, 409:860-921.
2. Venter J.C., et al. The sequence of the human genome. Science 2001, 291:1304-1351.
3. Wray G.A. The evolutionary significance of cis-regulatory mutations. Nat. Rev. Genet. 2007, 8:206-216.
4. Wittkopp P.J., Kalay G. Cis-regulatory elements: molecular mechanisms and evolutionary processes underlying divergence. Nat. Rev. Genet. 2012, 13:59-69.
5. Zheng W., et al. Regulatory variation within and between species. Annu. Rev. Genomics Hum. Genet. 2011, 12:327-346.
6. Kasowski M., et al. Variation in transcription factor binding among humans. Science 2010, 328:232-235.
7. Cookson W., et al. Mapping complex disease traits with global gene expression. Nat. Rev. Genet. 2009, 10:184-194.
8. Epstein D.J. Cis-regulatory mutations in human disease. Brief. Funct. Genomic Proteomic 2009, 8:310-316.
9. Worsley-Hunt R., et al. Identification of cis-regulatory sequence variations in individual genome sequences. Genome Med. 2011, 3:65.
10. Biggs R., et al. Christmas disease: a condition previously mistaken for haemophilia. Br. Med. J. 1952, 2:1378-1382.
11. Veltkamp J.J., et al. Another genetic variant of haemophilia B: haemophilia B Leyden. Scand. J. Haematol. 1970, 7:82-90.
12. Briet E., et al. Hemophilia B Leyden: a sex-linked hereditary disorder that improves after puberty. N. Engl. J. Med. 1982, 306:788-790.
13. Briet E., et al. The prophylactic treatment of hemophilia B Leyden with anabolic steroids. Ann. Intern. Med. 1985, 103:225-226.
14. Mandalaki T., et al. Haemophilia B Leyden in Greece. Thromb. Haemost. 1986, 56:340-342.
15. Reitsma P.H., et al. The putative factor IX gene promoter in hemophilia B Leyden. Blood 1988, 72:1074-1076.
16. Reitsma P.H., et al. Two novel point mutations correlate with an altered developmental expression of blood coagulation factor IX (hemophilia B Leyden phenotype). Blood 1989, 73:743-746.
17. Crossley M., Brownlee G.G. Disruption of a C/EBP binding site in the factor IX promoter is associated with haemophilia B. Nature 1990, 345:444-446.
18. Hirosawa S., et al. Structural and functional basis of the developmental regulation of human coagulation factor IX gene: factor IX Leyden. Proc. Natl. Acad. Sci. U.S.A. 1990, 87:4421-4425.
19. Crossley M., et al. A less severe form of Haemophilia B Leyden. Nucleic Acids Res. 1990, 18:4633.
20. Royle G., et al. Haemophilia B Leyden arising de novo by point mutation in the putative factor IX promoter region. Br. J. Haematol. 1991, 77:191-194.
21. Vidaud D., et al. Nucleotide substitutions at the -6 position in the promoter region of the factor IX gene result in different severity of hemophilia B Leyden: consequences for genetic counseling. Hum. Genet. 1993, 91:241-244.
22. Coyle T.E., et al. Moderate hemophilia B Leyden: identification by polymerase chain reaction, sequencing, and oligomer restriction. Am. J. Hematol. 1994, 46:234-240.
23. Hall A.J., et al. A single base pair deletion in the promoter region of the factor IX gene is associated with haemophilia B. Thromb. haemost. 1994, 72:799-803.
24. Morgan G.E., et al. The high frequency of the -6G>A factor IX promoter mutation is the result both of a founder effect and recurrent mutation at a CpG dinucleotide. Br. J. Haematol. 1995, 89:672-674.
25. Nielsen L.R., et al. Detection of ten new mutations by screening the gene encoding factor IX of Danish hemophilia B patients. Thromb. Haemost. 1995, 73:774-778.
26. Crossley P.M., et al. Unusual case of haemophilia B. Lancet 1989, 1:960.
27. Giannelli F., et al. Haemophilia B: database of point mutations and short additions and deletions - eighth edition. Nucleic Acids Res. 1998, 26:265-268.
28. Rallapalli P.M., et al. An interactive mutation database for human coagulation factor IX provides novel insights into the phenotypes and genetics of hemophilia B. J. Thromb. Haemost. 2013, 11:1329-1340.
29. Picketts D.J., et al. An A to T transversion at position -5 of the factor IX promoter results in hemophilia B. Genomics 1992, 12:161-163.
30. Reijnen M.J., et al. Hemophilia B Leyden: substitution of thymine for guanine at position -21 results in a disruption of a hepatocyte nuclear factor 4 binding site in the factor IX promoter. Blood 1993, 82:151-158.
31. Landschulz W.H., et al. Isolation of a recombinant copy of the gene encoding C/EBP. Genes Dev. 1988, 2:786-800.
32. Sladek F.M., et al. Liver-enriched transcription factor HNF-4 is a novel member of the steroid hormone receptor superfamily. Genes Dev. 1990, 4:2353-2365.
33. Davies N., et al. Clotting factor IX levels in C/EBP alpha knockout mice. Br. J. Haematol. 1997, 99:578-579.
34. Reijnen M.J., et al. Disruption of a binding site for hepatocyte nuclear factor 4 results in hemophilia B Leyden. Proc. Natl. Acad. Sci. U.S.A. 1992, 89:6300-6303.
35. Crossley M., et al. Recovery from hemophilia B Leyden: an androgen-responsive element in the factor IX promoter. Science 1992, 257:377-379.
36. Belvini D., et al. Molecular genotyping of the Italian cohort of patients with hemophilia B. Haematologica 2005, 90:635-642.
37. Wulff K., et al. Molecular analysis of hemophilia B in Poland: 12 novel mutations of the factor IX gene. Acta Biochim. Pol. 1999, 46:721-726.
38. Morgan G.E., et al. Further evidence for the importance of an androgen response element in the factor IX promoter. Br. J. Haematol. 1997, 98:79-85.
39. Heit J.A., et al. Haemophilia B Brandenberg-type promoter mutation. Haemophilia 1999, 5:73-75.
40. Ketterling R.P., et al. Two novel factor IX promoter mutations: incremental progress towards 'saturation in vivo mutagenesis' of a human promoter region. Hum. Mol. Genet. 1995, 4:769-770.
41. Rimmer E.K., et al. Unintended benefit of anabolic steroid use in hemophilia B Leiden. Am. J. Hematol. 2012, 87:122-123.
42. Andrew M., et al. Maturation of the hemostatic system during childhood. Blood 1992, 80:1998-2005.
43. Lowe G.D., et al. Epidemiology of coagulation factors, inhibitors and activation markers: the Third Glasgow MONICA Survey. I. Illustrative reference ranges by age, sex and hormone use. Br. J. Haematol. 1997, 97:775-784.
44. Green P.M., et al. The incidence and distribution of CpG-TpG transitions in the coagulation factor IX gene. A fresh look at CpG mutational hotspots. Nucleic Acids Res. 1990, 18:3227-3231.
45. Funnell A.P., et al. A CpG mutational hotspot in a ONECUT binding site accounts for the prevalent variant of hemophilia B Leyden. Am. J. Hum. Genet. 2013, 92:460-467.
46. Vaquerizas J.M., et al. A census of human transcription factors: function, expression and evolution. Nat. Rev. Genet. 2009, 10:252-263.
47. Jolma A., et al. DNA-binding specificities of human transcription factors. Cell 2013, 152:327-339.
48. An integrated encyclopedia of DNA elements in the human genome. Nature 2012, 489:57-74. ENCODE Project Consortium.
49. Laudadio I., et al. A feedback loop between the liver-enriched transcription factor network and miR-122 controls hepatocyte differentiation. Gastroenterology 2012, 142:119-129.
50. Odom D.T., et al. Control of pancreas and liver gene expression by HNF transcription factors. Science 2004, 303:1378-1381.
51. Rogaev E.I., et al. Genotype analysis identifies the cause of the 'royal disease'. Science 2009, 326:817.
52. Kurachi S., et al. Genetic mechanisms of age regulation of human blood coagulation factor IX. Science 1999, 285:739-743.
53. de Vooght K.M., et al. Management of gene promoter mutations in molecular diagnostics. Clin. Chem. 2009, 55:698-708.
54. Parker S.C., et al. Local DNA topography correlates with functional noncoding regions of the human genome. Science 2009, 324:389-392.
55. Schmidt D., et al. Five-vertebrate ChIP-seq reveals the evolutionary dynamics of transcription factor binding. Science 2010, 328:1036-1040.
56. Odom D.T., et al. Tissue-specific transcriptional regulation has diverged significantly between human and mouse. Nat. Genet. 2007, 39:730-732.
57. Stenson P.D., et al. The Human Gene Mutation Database (HGMD) and its exploitation in the fields of personalized genomics and molecular evolution. Curr. Protoc. Bioinform. 2012, 39:1.13.1-1.13.20.
58. De Gobbi M., et al. A regulatory SNP causes a human genetic disease by creating a new transcriptional promoter. Science 2006, 312:1215-1217.
59. Lettice L.A., et al. Point mutations in a distant sonic hedgehog cis-regulator generate a variable regulatory output responsible for preaxial polydactyly. Hum. Mol. Genet. 2008, 17:978-985.
60. Thurman R.E., et al. The accessible chromatin landscape of the human genome. Nature 2012, 489:75-82.
61. Rhee H.S., Pugh B.F. Comprehensive genome-wide protein-DNA interactions detected at single-nucleotide resolution. Cell 2011, 147:1408-1419.
62. Kheradpour P., et al. Systematic dissection of regulatory motifs in 2000 predicted human enhancers using a massively parallel reporter assay. Genome Res. 2013, 23:800-811.
63. Berger M.F., Bulyk M.L. Universal protein-binding microarrays for the comprehensive characterization of the DNA-binding specificities of transcription factors. Nat. Protoc. 2009, 4:393-411.
64. Maurano M.T., et al. Systematic localization of common disease-associated variation in regulatory DNA. Science 2012, 337:1190-1195.
65. Gaj T., et al. ZFN, TALEN, and CRISPR/Cas-based methods for genome engineering. Trends Biotechnol. 2013, 31:397-405.
66. Biggin M.D. Animal transcription networks as highly connected, quantitative continua. Dev. Cell 2011, 21:611-626.
67. Tewari A.K., et al. Chromatin accessibility reveals insights into androgen receptor activation and transcriptional specificity. Genome Biol. 2012, 13:R88.
68. Portales-Casamar E., et al. JASPAR 2010: the greatly expanded open-access database of transcription factor binding profiles. Nucleic Acids Res. 2010, 38:D105-D110.
69. Simpson N.E., Biggs R. The inheritance of Christmas factor. Br. J. Haematol. 1962, 8:191-203.